lenalidomide has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gribben, JG; Ramsay, AG | 1 |
1 review(s) available for lenalidomide and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.
Topics: Antineoplastic Agents; Chronic Disease; Humans; Immunologic Factors; Lenalidomide; Leukemia, T-Cell; Thalidomide | 2009 |